Skip to content
10-Q

Quarterly Report

AIFARM, LTD.

0001654954-19-009769

← back to feed
Filed
Aug 19, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Stock Issued Q2 2019 · Jun 30, 2019 5.63M sh
Shares Outstanding Q2 2019 · Jun 30, 2019 56.2M sh
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$262.89K
Operating Cash Flow restated Q2 2019 · Jun 30, 2018 −$743.4K
Stockholders Equity Q2 2019 · Jun 30, 2019 −$1.9M
Stockholders Equity Q2 2019 · Dec 31, 2018 −$1.95M
Total Liabilities Q2 2019 · Jun 30, 2019 $3.54M
Total Liabilities Q2 2019 · Dec 31, 2018 $3.59M
Total Assets Q2 2019 · Jun 30, 2019 $94.11K
Total Assets Q2 2019 · Dec 31, 2018 $97.12K
Sga Expense Q2 2019 · Jun 30, 2019 $76.46K
Sga Expense Q2 2019 · Jun 30, 2019 $211.81K
Sga Expense restated Q2 2019 · Jun 30, 2018 $9.59K
Sga Expense restated Q2 2019 · Jun 30, 2018 $44.66K
Net Income Q2 2019 · Jun 30, 2019 −$76.46K
Net Income Q2 2019 · Jun 30, 2019 −$211.81K
Net Income Q2 2019 · Jun 30, 2018 −$9.59K
Net Income Q2 2019 · Jun 30, 2018 −$44.66K